semaglutide patient teaching Active Learning Template: Medication Overview Semaglutide: Double-edged Sword with Risks

While the drug has generally been well tolerated by patients, like any other medication with side effects, it can have some side effects that can interfere with productivity on a daily basis

For type 2 diabetes management , NICE guideline NG28 recommends considering GLP-1 receptor agonists when: Triple therapy with metformin and two other oral medications is ineffective, not tolerated or contraindicated The patient has a body mass index (BMI) of 35 kg/m or higher (with lower thresholds for people from certain ethnic backgrounds), or lower BMI with specific clinical circumstances where weight loss would benefit other obesity-related comorbidities Insulin would have significant occupational implications GLP-1 therapy should only be continued beyond six months if there has been a beneficial metabolic response, defined as a reduction in HbA1c of at least 11 mmol/mol (1.0 percentage point) and weight loss of at least 3% of initial body weight

/ + GLP-1 TERRA ELMNT -

Both medicines also slow how fast food leaves your stomach

AW designed the study, analyzed the data, wrote the article